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Abstract
Leucine-rich Repeat Containing protein 10 (LRRC10) has recently been identified as a cardiac-specific factor in mice. However, the function
of this factor remains to be elucidated. In this study, we investigated the developmental roles of Lrrc10 using zebrafish as an animal model.
Knockdown of Lrrc10 in zebrafish embryos (morphants) using morpholinos caused severe cardiac morphogenic defects including a cardiac
looping failure accompanied by a large pericardial edema, and embryonic lethality between day 6 and 7 post fertilization. The Lrrc10 morphants
exhibited cardiac functional defects as evidenced by a decrease in ejection fraction and cardiac output. Further investigations into the underlying
mechanisms of the cardiac defects revealed that the number of cardiomyocyte was reduced in the morphants. Expression of two cardiac genes was
deregulated in the morphants including an increase in atrial natriuretic factor, a hallmark for cardiac hypertrophy and failure, and a decrease in
cardiac myosin light chain 2, an essential protein for cardiac contractility in zebrafish. Moreover, a reduced fluorescence intensity from NADH in
the morphant heart was observed in live zebrafish embryos as compared to control. Taken together, the present study demonstrates that Lrrc10 is
necessary for normal cardiac development and cardiac function in zebrafish embryos, which will enhance our understanding of congenital heart
defects and heart disease.
© 2007 Elsevier Inc. All rights reserved.Keywords: Leucine-rich Repeat Containing protein 10; Heart development; Cardiac function; Zebrafish embryos; Cardiac looping defects; Pericardial edemaIntroduction
Identification of molecular pathways involved in normal
heart development will lead to the discovery of the genetic basis
for human congenital heart disease as well as adult cardiac
disease. Therefore, a better understanding of molecular
mechanisms underlying normal cardiac development and
function is a major focus of modern cardiovascular research
(for reviews, see Chien, 2000; Gruber and Epstein, 2004;
Heideman et al., 2005; Olson, 2004; Olson and Schneider,
2003; Srivastava and Olson, 2000). Cardiac development is a
complex biological process requiring the integration of cell
specification, differentiation, and morphogenesis. Many factors⁎ Corresponding author. Fax: +1 608 262 7306.
E-mail address: youngsooklee@wisc.edu (Y. Lee).
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doi:10.1016/j.ydbio.2007.06.005have been implicated in this process on the basis of their spatial
and temporal expression patterns or their phenotypic effects
when they are functionally inactivated in various animal
models. These include diverse families of transcription factors,
including Nkx2.5 (Lyons et al., 1995; Schott et al., 1998),
GATA4 (Kuo et al., 1997; Molkentin et al., 1997), Tbx5, and
Tbx20 (Bruneau et al., 2001; Krause et al., 2004; Stennard et al.,
2005), and Jumonji/Jarid2, (Jung et al., 2005; Lee et al., 2000),
and Fog-1 (Walton et al., 2006). In addition, secreted factors
with their receptors (Bujak and Frangogiannis, 2006; Schneider
et al., 2003), and cytoplasmic and contractile proteins (Bendig
et al., 2006; Berdougo et al., 2003; Rottbauer et al., 2006) have
been shown to be critical for cardiac development. However, the
exact molecular mechanisms of embryonic cardiac develop-
ment remain to be elucidated.
Therefore, we reasoned that there are yet unidentified cardiac
factors that play critical roles in normal heart development as
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have identified a mouse gene encoding Leucine-rich Repeat
Containing protein 10 (LRRC10) as a cardiac-specific gene by
employing in silico approaches (Passier et al., 2000; Wang et
al., 2001), which exhibits dynamic expression patterns during
development (Kim et al., in press). While we were characteriz-
ing this factor in zebrafish, LRRC10 was reported as a cardiac-
restricted (HRLRRP) or cardiac-specific factor (SERDIN1) in
mice (Adameyko et al., 2005; Nakane et al., 2004). Herein, we
will refer to this gene as LRRC10 in accordance with the NCBI
nomenclature. However, the developmental and molecular
function of LRRC10 remains completely unknown.Fig. 1. Cardiac-specific expression of zlrrc10. (A) The genomic structure of zlrrc10. T
the 5′ and 3′ UTR regions are shown in bp. The amino acid coding regions are rep
LRRC10 amino acid sequences. Identical residues between all three species are sh
conserved seven LRR motifs are numbered. (C) Cardiac-specific expression of lrrc1
subjected to whole-mount in situ hybridization using digoxigenin labeled zlrrc10 ant
positive control to visualize the heart. Negative control was hybridized with sense zlrr
and cmlc2. A and V indicate the atrium and ventricle, respectively. (D) Cardiac-specif
total RNA isolated from three different parts of adult zebrafish as indicated. The zlrrc
plasmid pCRII-TOPO-zlrrc10 was used as positive control for the amplification reaLeucine-rich repeat (LRR) motifs are present in an
increasing number of proteins with diverse functions such as
enzyme inhibition, cell growth, cell adhesion, signal transduc-
tion, regulation of gene expression, apoptosis signaling, and
development (Kobe and Kajava, 2001). LRR motifs are present
in over 2000 proteins from viruses to eukaryotes. LRRs are 20–
29 residue sequence motifs and the repeat number ranges from 2
to 45. The primary function of these motifs is believed to
provide a structural framework for protein–protein interactions.
Mouse and human LRRC10 contain seven LRR motifs and do
not contain any N-terminal or C-terminal domains that are often
present in other LRRC proteins (Fig. 1B). These additionalhe full-length zlrrc10 cDNA consists of two exons. The size of exons, intron and
resented by the hatched box. (B) An alignment of zebrafish, mouse and human
aded black, and the residues with similar characteristics are shaded gray. The
0 in zebrafish embryos. Zebrafish embryos at 1 dpf (a–c) and 2 dpf (d–f) were
isense cRNA probes (a, d). cmlc2 antisense cRNA probe (b and e) was used for
c10 probe (c and f). Arrows indicate the linear heart region that expresses zlrrc10
ic expression of zlrrc10 in adult zebrafish. RT-PCR analysis was performed using
10 PCR products of 581 bp were visualized by agarose gel electrophoresis. The
ctions. RT-PCR of β-actin was performed as a loading control.
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such as a kinase domain or a membrane spanning domain
(Buchanan and Gay, 1996). Therefore, the LRRC10 gene
product represents a unique member of the LRRC protein
family, which contains only the leucine-rich repeat motif. The
LRRC10 gene is conserved in most vertebrates including
mouse, rat, human, chicken, and frog, suggesting an important
function in an evolutionally conserved manner. Therefore, we
set out to identify the roles of Lrrc10 in cardiac development
using zebrafish (Danio rerio) as a vertebrate model.
The zebrafish has become a popular model for the study of
cardiovascular development. It presents a prototypic verte-
brate heart with only a single atrium and ventricle. The
molecular mechanisms governing its patterning appear to be
similar to those in more complex hearts of higher vertebrates
(Fishman and Chien, 1997; Weinstein and Fishman, 1996).
Assessing early embryonic heart morphology and function is
facilitated in zebrafish embryos because they are transparent
and not dependent on intact cardiovascular function during
the first 6–7 days of development (Pelster and Burggren,
1996). The heart is the first definitive organ to develop and
become functional as survival depends on its proper function.
However, there is a period when the heart is already func-
tional, but not yet essential in the early developmental stages.
In the zebrafish embryos, this period actually lasts for several
days because of the small size and relatively low metabolism.
This enables analysis of mutants with compromised or no
cardiac function for a considerable period of time (Stainier
and Fishman, 1992; Stainier et al., 1996). In contrast a similar
phenotype in the mouse would result in early embryonic
lethality.
In this study, we describe the novel developmental roles of
Lrrc10 in early cardiac development and function in zebrafish.
The remarkable cardiac-specific expression of lrrc10 was
observed in zebrafish. To identify the developmental roles of
Lrrc10, Lrrc10 expression was reduced using lrrc10-specific
antisense morpholinos. Knockdown of Lrrc10 caused early
morphological defects such as cardiac looping defects accom-
panied by a large pericardial edema, suggesting cardiac
insufficiency. In addition, defects in cardiac function were
observed as evidenced by decreased ejection fraction and
cardiac output. Further investigations into the underlying
mechanisms of the cardiac defects indicated that the number
of cardiomyocytes was reduced in the morphants. In addition,
expression of important cardiac genes was deregulated in the
morphants such as atrial natriuretic factor, a hallmark for cardiac
failure, and cardiac myosin light chain 2, an essential protein for
cardiac contractility. In addition, a reduced amount of NADH in
the morphant heart was observed in live zebrafish embryos as
compared to control, suggesting a decrease in energy reserve
due to Lrrc10 reduction. The results presented here indicate that
Lrrc10 is essential for early cardiac development and function in
zebrafish embryos. Therefore, this study will provide a critical
foundation to further study the biological functions of Lrrc10 in
cardiomyocytes, which will enhance our understanding of the
mechanisms that lead to normal cardiac development and
function.Materials and methods
Zebrafish maintenance
A cmlc2:dsRed2-nuc line of transgenic zebrafish (AB background) that
expresses red fluorescent protein (RFP) specifically in the cardiomyocyte
nucleus was used to determine the number of cardiac myocytes. A transgenic
cmlc2::GFP zebrafish line (AB background) that marks cardiomyocytes with
Green Fluorescence Protein (GFP) was used to visualize the abnormal
contractions as described below (see Movies S1 and S2). The wild type AB
strain of zebrafish was used for all other experiments. Pooled embryos from
group matings were used in all experiments to control for variability between
different clutches of embryos. All fish were bred and embryos were raised
according to the procedures as described elsewhere (Westerfield, 1995). When
applicable, fish were anesthetized with 1.67 mg/ml tricaine (Sigma).
Cloning of a full-length zebrafish lrrc10 cDNA
To identify novel cardiac-specific genes that are exclusively expressed in the
heart, we performed a virtual subtractive screen (in silico approach) as described
previously (Adameyko et al., 2005; Nakane et al., 2004; Passier et al., 2000;
Wang et al., 2001). Mouse Expression Sequence Tag (EST) databases from
embryonic day (E)13 heart were searched using the NCBI database. By
subtracting genes that are expressed in other organs, we identified a list of
putative cardiac-specific genes. These genes were subsequently subjected to in
situ hybridization and Northern blot analyses to examine the expression patterns.
From this expression screening, a mouse gene encoding Leucine-rich Repeat
Containing protein 10 (LRRC10) was identified as a cardiac-specific gene (Kim
et al., in press).
Zebrafish lrrc10 (zlrrc10) was cloned by RT-PCR using gene specific
primers based on the reported zlrrc10 cDNA sequence, forward (F) 5′-
ACAGGAGCATCAAACACCA and reverse (R) 5′-ACAAAAGTCACTAA-
TTCACTC (Genbank nucleotide accession number; GI57222256). Total RNA
was isolated from the adult zebrafish heart with Trizol Reagent (Invitrogen) and
first-strand cDNAwas synthesized from 1 μg total RNA by reverse transcriptase
(SuperScriptIII, Invitrogen) with oligo (dT) primers followed by PCR. The
profile for PCR reaction was 94 °C for 5 min, followed by 30 cycles of
denaturation 94 °C for 1 min, annealing at 56 °C for 1 min, and extension at
72 °C for 1 min, then 7 min at 72 °C for the final extension. The full-length PCR
product of 973 bp consisting of the entire coding sequence, 5′ and 3′
untranslated region was subcloned into pCRII-TOPO vector (Invitrogen)
followed by sequencing. The nucleotide sequence of the cloned zlrrc10 is
identical to the reported sequence.
To detect zlrrc10 in adult tissues (Fig. 1D), RT-PCR was performed as above
using total RNA isolated from three different parts of adult zebrafish followed
by PCR amplification with the following primers: zlrrc10, F 5′-CACGGC-
CACCAGTTTTC, R 5′-GGCGGGTAAACTCCGTAG; β-actin, F 5′-CACGA-
GACCACCTTCAACT, R 5′-CATTGTGAGGAGGGCAAAG.
Antisense morpholino experiments
Two independent antisense morpholinos (MOs) targeted against the
translational start site of zlrrc10 were synthesized (Gene Tools). MOs were 3′
labeled with FITC to monitor for uniform oligonucleotide distribution in
injected embryos. The morpholino sequences used were as follows: zlrrc10-
MO1 (MO1, target −11 to +14), 5′-ACAACAT TTCCCATCTTCTTGGCCC;
zlrrc10-MO1–5 bp mismatched control morpholino (CMO-5m), 5′-ACAAGAT
TTGCCATGTTGTTGGGCC, mismatched base pairs indicated in bold;
zlrrc10-MO2 (MO2, target −32 to −8), 5′-GCCCAAAATCATGGTCTCA-
GGTAGC.
The specificity of zlrrc10 morpholinos was confirmed by using a standard
scrambled control morpholino (CMO) 5′-CCTCTTACCTCAGTTACAATT-
TATA (Gene Tools) and CMO-5m morpholino. The ability of MOs to
specifically block translation of its cognate mRNA was analyzed using an in
vitro transcription and translation assay (TNT kit; Promega). Briefly, in vitro
transcription and translation of pCRII-TOPO-zlrrc10 was performed using T7
RNA polymerase. Reactions were performed according to manufacturer's
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0.75 μl of [35S]-methionine, in the presence or absence of various final
concentrations of MO1, CMO, CMO-5m, or MO2 as indicated. After 90 min
incubation at 30 °C radioactive translation products were resolved by 10%
polyacrylamide gel electrophoresis followed by autoradiography.
The microinjection (Narishige IM300 Microinjector) of newly fertilized
eggs was preformed at the 1–2 cell stages with approximately 2 nl of the
appropriate morpholino solution (0.15 mM of zlrrc10-MO1, CMO or CMO-5m)
(Antkiewicz et al., 2006). For MO2 injections, we used 0.75 mM of zlrrc10-
MO2 or CMO. 1× Danieau's solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM
MgSO4, 0.6 mM Ca(NO3)2, 5 mM N-(2-hydroxyethyl)-piperazine-N′-2-ethane-
sulfonic acid, pH 7.6) was used to dilute all morpholino stocks to the concen-
tration appropriate for injection. The morpholino solution was injected
approximately at the border between the cell and yolk, with a needle positioned
such that it was piercing the cell. Embryos were screened under fluorescent light
to determine injection success and even distribution of morpholino within the
embryo at approximately 2 h postinjection.
Whole-mount in situ hybridization, immunostaining, and histology
To study the expression of zlrrc10, anf and cmlc2 mRNA in zebrafish
embryos, pCRII-TOPO-zlrrc10 and pCRII-TOPO-anf plasmid were cloned.
cmlc2 was a kind gift from Dr. Randall Peterson. To clone the partial anf cDNA,
RT-PCR was performed using total RNA from the zebrafish adult heart with the
following pairs of oligonucleotide primer sequences: anf: F 5′-ACACGTT-
GAGCAGACACAGC, R 5′-TGTTAACAAATTAAGCCGTATTGT.
Whole-mount in situ hybridization of zebrafish embryos was carried out by
using digoxigenin-11-UTP-labeled probes (Roche Diagnostics Corp) as
previously described (Yelon et al., 1999). The antisense probes for full-length
zlrrc10, anf, and cmlc2 were synthesized by linearizing their respective
plasmids with NotI and using Sp6 RNA polymerase. The sense probe for
zlrrc10 was synthesized for negative control by linearizing the pCRII-TOPO-
zlrrc10 plasmid with HindIII and using T7 RNA polymerase. To quantitatively
analyze the differences of gene expression, semi-quantitative RT-PCR was
performed. Briefly, following first-strand cDNA synthesis, PCR amplifications
were performed with 2% of the first-strand reaction, 1 unit of Taq polymerase
(Denville Scientific Inc, Metuchen, NJ), and 25 pmol of the appropriate primers
in a reaction volume of 25 μl. The amplification was done at 94 °C for 1 min
followed by 24 cycles of 94 °C for 30 s, annealing at 55 °C for 30 s, and
extension at 72 °C for 30 s. A final extension at 72 °C for 7 min was performed.
Gene-specific primers for cmlc2 are F 5′-ACCGGGATGGAGTTATCA, and R
5′-CTCCTGTGGCATTAGGG. The authenticity of the amplified products was
determined by size analysis on agarose gels.
Immunostaining of zebrafish embryos was performed as previously
described (Berdougo et al., 2003) using the monoclonal antibody MF20 that
recognizes the myosin heavy chain (MHC). Briefly, embryos fixed in 4%
paraformaldehyde were dehydrated in a methanol series. For staining,
rehydrated embryos were permeabilized by digestion in collagnase (1 mg/ml)
for 30–40 min. Permeabilized larvae were blocked in 10% normal calf serum in
PBS with 0.1% Tween-20 for 1 h. After overnight incubation with the MF20
antibody, embryos were incubated with a secondary antibody (Alexa-546
conjugated goat anti-mouse, Molecular Probes, OR, USA) for 5 h at room
temperature and visualized by epifluorescence microscopy.
Histological experiments were performed by standard hematoxylin and
eosin staining (H&E) as previously described (Lee et al., 2000). Zebrafish
embryos fixed in 4% paraformaldehyde were serially dehydrated to 100%
ethanol for paraffin embedding. Paraffin embedded embryos were sectioned at
10 μm thickness and stained with H&E to examine histology of the heart.
Red blood cell (RBC) perfusion rate and analyses of the number of
cardiac myocytes
As an index of regional blood flow, RBC perfusion rate was measured in one
readily identifiable vessel, the intersegmental blood vessel (ISV) in the tail as
described elsewhere (Trumpp et al., 2001). Embryos were mounted in 3%
methyl cellulose (Sigma) and high-speed video time-lapse recordings (125
frames per second) were used to image RBCs passing through an ISV of the
mounted zebrafish in a 3 s period. These recordings were captured using aMotion Scope camera (Redlake) and a Nikon TE300 inverted microscope with a
10× lens. The total number of RBCs passing through an ISV during the entire
recording was counted.
Cardiac myocytes were counted at 3 and 4 days post fertilization (dpf) in
cmlc2::dsRed2-nuc transgenic zebrafish (Antkiewicz et al., 2005; Mably et al.,
2003) using the method described by Antkiewicz et al. (2005). Briefly, embryos
were anesthetized and flat-mounted on a glass microscope slide under a
coverslip in Lebovitz's L15 cell culture media (Invitrogen). Epifluorescence
images were captured using the Nikon TE300 inverted microscope (20× lens)
and a Princeton Instruments Micromax charge-coupled device camera. Total
number of visible cardiac myocyte nuclei per heart was counted.
Cardiac functional analyses
End-diastolic volume (EDV) and end-systolic volume (ESV), as well as
stroke volume and cardiac output were determined at 3, 4, and 5 dpf from time-
lapse recordings (Motion Scope camera, 250 frames/s) of a lateral view of a
beating zebrafish heart as described previously (Antkiewicz et al., 2006; Carney
et al., 2006). Briefly, frames representative of the ventricle in end-systole and
end-diastole were used to calculate volume of the ventricle for both states
according to the method of discs (Coucelo et al., 2000). This method assumes
that ventricular volume can be represented as the sum of the volumes of
individual discs into which the ventricle can be sliced. The two-dimensional
image of the ventricle at end-diastole and end-systole was divided into slices of
10 μm thickness and their volume was assessed using the MetaMorph Imaging
System (Universal Imaging Corporation). Time-lapse recordings of the heart
were also used to calculate heart rate (HR), which was determined from
the number of frames in which three consecutive heart contractions occurred.
Stroke volume (SV) was calculated from the approximated EDV and ESV:
SV=EDV−ESV; cardiac output (CO)=SV×HR.
Multiphoton fluorescence imaging
NADH is an intrinsically fluorescent molecule, which allows one to monitor
NADH fluorescence to dynamically interpret the metabolic activity in vivo
(Chance et al., 1962; Pappajohn et al., 1972). NADH images of the heart in live
zebrafish embryos were collected with a purpose-built multiphoton imaging
system (LOCI at the University of Wisconsin, Madison) (Bird et al., 2004; Bird
et al., 2005). Briefly, a titanium sapphire laser (Coherent, Mira) tuned to
wavelength at 780 nm excitation was the two-photon excitation source. The
excitation light was sent to and the emitted light was collected from the sample
through an inverted microscope (Nikon, TE2000U) with a 40× objective
(Nikon, PlanApo NA 1.4) coupled to a laboratory-developed laser scanning
system. Synchronized fluorescence data collection on a pixel-by-pixel basis was
achieved using the x and y laser scanning signals generated for the laser
scanning electronics. Acquisition was done with WiscScan, a laboratory-
developed acquisition package (Bird et al., 2004).
Statistical analyses
One-way analysis of variance followed by the Fisher least significant
difference test was used to determine statistical significance. The assumption of
unequal variances for all data sets was checked using Levene's test. Results are
presented as mean±standard error of the mean (SEM), and asterisks indicate a
significant difference at pb0.05, or 0.01 as indicated. All analyses were
performed using the Statistica 7.0 software package. In all cases, the observer
was blinded to the treatment group until measurements or scoring was
completed.Results
Examination of zlrrc10 expression patterns
Information on the detailed expression patterns of a gene
provides an important basis for understanding the biological
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specific expression of LRRC10 in mouse (Adameyko et al.,
2005; Nakane et al., 2004) (Kim et al., in press) and human
(data not shown, 2007), we set out to determine whether Lrrc10
plays critical roles in cardiac development in the zebrafish
embryo. It presents a prototypic vertebrate heart because the
molecular mechanisms regulating cardiac development in
zebrafish appear to be similar to those in more complex hearts
of higher vertebrates (Weinstein and Fishman, 1996; Fishman
and Chien, 1997).
In preparation for investigating the developmental roles of
Lrrc10, we first examined the expression patterns of zlrrc10 in
zebrafish embryos by whole-mount in situ hybridization using
an antisense zlrrc10 probe (Fig. 1). The full-length cDNA
consisting of the coding sequence and 5′ and 3′ untranslated
regions of zlrrc10 was cloned by RT-PCR as described in
Materials and methods section. The full-length zlrrc10 cDNA is
encoded by two exons as depicted in Fig. 1Awhereas the mouse
LRRC10 is encoded by one exon. The coding sequence of
zLrrc10 contains 270 amino acids, which is highly homologous
to the mouse and human LRRC10, suggesting the conserved
function of this gene product (Fig. 1B). The primary amino acid
sequence of zLrrc10 is 62% or 64% identical to the mouse or
human LRRC10, respectively. If the similar amino acids are
included, the homology is 73% or 76% to the mouse or human
LRRC10, respectively. The zLrrc10 consists of seven LRR
motifs without any known functional domain as in mouse and
human LRRC10.
To perform whole-mount in situ hybridization, zebrafish
cardiac myosin light chain 2 (cmlc2) was used as a positive
cardiac marker gene to visualize the developing heart (Fig. 1C,
b and e). It has been demonstrated that cmlc2 is expressed both
in the embryonic ventricle and atrium of zebrafish (Rottbauer et
al., 2006; Yelon et al., 1999). lrrc10 in zebrafish was detected
specifically, but weakly in the linear heart tube of 1 dpf embryos
followed by a marked increase in the heart of 2 dpf embryos
(Fig. 1C, a and d). zlrrc10 expression appears to be higher in the
ventricle than the atrium, but it should be noted that the atrium
contains fewer cardiomyocytes than the ventricle. zlrrc10 was
not detected in any other tissues or organs in developing
embryos. The negative control using a sense-zlrrc10 probe did
not show any staining (Fig. 1C, c and f), indicating specificity of
the antisense zlrrc10 probe. The cardiac-specific expression
continues in adult zebrafish as indicated by RT-PCR assays. The
zlrrc10 transcripts were detected only in the heart, but not in the
head or tail region of adult zebrafish (Fig. 1D). These results
demonstrate the cardiac-specific expression of lrrc10 in
zebrafish from 1 dpf to adult.
Examination of morpholinos
To determine whether Lrrc10 plays critical roles in cardiac
development, we performed antisense morpholino (MO)
experiments during early zebrafish development. Zebrafish
are well suited for gene function studies using MOs due to their
rapid external development, transparent embryos, and the ease
of delivery of the intervening MOs. We designed morpholinosagainst the translation initiation site in zlrrc10 mRNA to reduce
Lrrc10 protein level in zebrafish embryos. The ability of
morpholinos to block translation of zlrrc10 was examined using
an in vitro translation reaction in the absence or presence of
morpholino (Fig. 2A). In vitro translated and [35S]-methionine
labeled Lrrc10 was detected as a single band at the expected size
of 31 kDa (indicated by +). MO1 completely blocked trans-
lation of zlrrc10 at 0.26 μM whereas the control morpholino
(CMO) did not inhibit translation even at a higher concentration
of 1.3 μM. MOs display sequence-specific inhibition over a
wide concentration range: 3–3000 nM in cell-free translation
systems (Sumanas and Larson, 2002). To further confirm the
specificity of MO1, we tested MO1 containing five mismatched
base pairs (CMO-5m) as an additional specific negative control.
CMO-5m did not block translation of zlrrc10, indicating the
specific effect of MO1 on blocking translation of zlrrc10.
It is important to use stringent negative controls for antisense
experiments. While MOs can exhibit specific inhibition over a
wide concentration range, non-specific interactions still happen,
especially at higher doses. One likely reason for the possible
non-specific effects is mistargeting. While random sequences of
MOs are widely used as a control for general toxicity of MOs,
and embryo handling, it does not address MO mistargeting,
which is the likely cause of non-specific phenotypes. It becomes
necessary to confirm the specificity of novel phenotypes either
by RNA rescue or by using another MO of different sequence
targeted against the same gene. RNA rescue is often compli-
cated due to RNA overexpression artifacts and the inability to
mimic the endogenous spatial and temporal gene expression
pattern that is often critical for the proper function of the gene.
This is the case for rescue experiments for Lrrc10 knockdown
embryos because zlrrc10 is a cardiac-specific gene. However,
the mistargeting issue is well addressed when two MOs of
different sequence against the same gene produce the same
phenotype. Therefore, we synthesized a different zlrrc10
morpholino, MO2, which also blocked the translation of
zlrrc10 in vitro, but to a much lesser extent than MO1 (Fig.
2A). MO2 blocked the translation with about 90% efficiency at
3 μM while CMO did not (data not shown). Having confirmed
the specific activity of zlrrc10 morpholinos in blocking
translation in vitro, we generated the Lrrc10 knockdown
embryos to examine the developmental roles of Lrrc10.
Knockdown of Lrrc10 caused cardiac morphological defects
To investigate the role of Lrrc10 in zebrafish development,
we injected each morpholino into one-cell stage zebrafish
embryos as described in the Materials and methods section and
allowed them to develop for 6–7 dpf. The zlrrc10-MO1
knockdown embryos (morphants) did not show gross abnorm-
alities at 1 dpf (data not shown). In normal zebrafish embryos,
by 26 h post fertilization (hpf), the heart tube is formed and
elongated to form an asymmetrically located tube, which then
undergoes looping (Heideman et al., 2005). At about 36 hpf, the
ventricular cells move to the right of the atrium in a process
known as rightward looping, which lasts until approximately
48 hpf. Initially peristaltic waves of contraction in the simple
Fig. 2. Effects of zlrrc10-MO1 on the zebrafish heart morphology and blood flow. (A) The effect of zlrrc10-MOs on blocking translation of zlrrc10. zlrrc10 cDNA
yielded a [35S]-methionine labeled 31 kDa protein by in vitro transcription and translation reaction (+). Negative control (−) was incubated without template plasmid.
To determine the effect of zlrrc10-MOs, zlrrc10 cDNAwas in vitro translated in the presence of MO1 or MO2. To confirm the specificity of zlrrc10MOs, two control
morpholinos, CMO or CMO-5m were used. The final concentrations of morpholinos in the reaction are indicated. (B) Knockdown of Lrrc10 caused heart defects.
CMO (a and d) and MO1 (b, c, e, and f) injected zebrafish were imaged at 3 dpf. d–f are high-power images of a–c, respectively, which show heart looping defects of
the morphants (e and f). The arrowhead indicates a large pericardial edema. Blue and red indicate the ventricle and atrium, respectively. A, atrium; V, ventricle. (C)
Reduced blood flow in the morphants. Zebrafish embryos were injected with zlrrc10-MO1 (hatched bar) or CMO (open bar). RBC perfusion rates in an intersegmental
vessel were determined between 2 and 5 dpf as described in Materials and methods section. An asterisk indicates a significant difference in values between the test
CMO and the MO1 at pb0.05.
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48 hpf, much of the basic architecture of the heart has formed,
and a process of maturation continues in which the myocardial
walls thicken and become trabeculated and actual valve leaflets
form.
However, starting at 2 dpf, the zlrrc10 morphants exhibited
gross abnormalities including a large pericardial edema and
cardiac looping defects. The representative images of control (a
and d) and the morphants (b, c, e and f) at 3 dpf are shown in
Fig. 2B. The zlrrc10 morphants showed a large pericardial
edema that was readily apparent (indicated by arrow Fig. 2B, b
and c) that is absent in control (Fig. 2B, a), suggesting cardiac
insufficiency. We did not observe any significant general
toxicity in the control embryos (Fig. 2B, a). Because the heart
has undergone looping in the control embryos, the ventricle and
atrium of the control embryos are overlapped and not
distinguishable by the lateral view (Fig. 2B, d). In contrast,
the zlrrc10 morphants exhibited prominent looping defects at
higher magnification as shown by two representative morphants
(Fig. 2B, e and f). Most zlrrc10 morphants showed a completelooping failure, resulting in the linear heart with a stretched
string-like atrium (Fig. 2B, e) or a round atrium (Fig. 2B, f).
Some zlrrc10 morphants showed a partially looped heart (see
Fig. 3G).
We analyzed the morphants daily and the results from four
independent microinjection experiments are summarized in
Table 1. The looping defect persisted and pericardial edema
became progressively larger, suggesting severe cardiac insuffi-
ciency. By 4 dpf, about 90% of morphants showed looping
defects with a large pericardial edema. The morphology of the
ventricle in the morphants became abnormal by 4 dpf, as shown
by it being compact and small compared to that of control
embryos (see Fig. 3).
The tubular hearts in the morphants were able to contract and
drive the circulation, but not as effectively as the control heart as
evidenced by markedly slower moving blood cells in the ISVs
(Fig. 2C). The number of blood cells passing through ISV in the
tail caudal to the yolk was significantly decreased in the
morphants. As early as 36 hpf, heart contractions appeared
visibly abnormal or incomplete in zlrrc10 morphants, and this
Fig. 3. Histological analysis reveals cardiac defects in the zlrrc10 morphants.
Zebrafish embryos injected with CMO (A–D) and MO1 (E–H) were fixed at
4 dpf and paraffin embedded. The embryos were sectioned (10 μm) and stained
with H&E. Serial transverse sections are shown from the anterior end at the top
of the figure and progressing to the posterior end at the bottom. Arrowhead
indicates a large pericardial edema; BA, bulbus arteriosus; A, atrium; V,
ventricle.
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data provided by a movie using a transgenic zebrafish line
cmlc2::GFP). In contrast, vigorous contractions were observedTable 1
Phenotype analyses of embryos injected with zlrrc10 or control morpholinos
Looping defect (%)
MO1 n CMO n CMO-5m n MO2 n
2 dpf 82.6±2.4 125 3.4±1.8 145 6.1±1.5 82 77.2±1.0 4
3 dpf 89.5±3.7 124 2.1±1.2 114 9.0±2.8 66 78.8±3.8 4
4 dpf 91.9±3.7 107 1.9±1.2 91 9.9±0.8 50 78.2±8.1 3
5 dpf 97.7±1.6 80 2.2±1.6 77 6.9±202 43 80.2±10.2 3
Four or two independent microinjection experiments were performed for MO1 or Min control embryos. These results led us to analyze the cardiac
function as described below (Fig. 4). Although the morphology
of the heart was abnormal and cardiac function appeared
defective, the morphants survived until 6–7 dpf when viability
in the morphant started to deteriorate, as indicated by either no
heart beat or a very weak heart beat.
To confirm that the effect of MO1 on cardiac development is
caused by knockdown of Lrrc10, rather than non-specific effect
due to mistargeting, zlrrc10-MO2 that is targeted at a different
site was tested. As summarized in Table 1, MO2 injection also
caused cardiac looping defects and pericardial edema in the
morphants, which is the same phenotype by MO1 injection.
Cardiac looping defects persisted during the course of
examination, which were observed in about 80% of the MO2
morphants (Table 1). A large pericardial edema was observed in
up to 66% of the MO2 morphants at 3 dpf followed by recovery
at 4 and 5 dpf, suggesting cardiac function was improved as the
morphants developed. It should be noted that MO2 blocks
translation much less efficiently than MO1 (Fig. 2A). Moreover,
it is highly likely that the effect of MO2 is reduced because the
concentration of MO is diluted as embryos develop and the
level of zLrrc10 expression increases as the heart develops (Fig.
1C, a and b; data not shown, 2007). In fact, it is believed that
MOs are most efficient during the first 2 or 3 days of
development, possibly due to dilution by ongoing cell divisions
and by elimination from the embryo body due to metabolism
and excretion of the MO (Sumanas and Larson, 2002).
Nevertheless, it is interesting that the MO2 morphants with
abnormal cardiac morphologies at 4–5 dpf seem to have
improved cardiac function. We have not observed any defects in
other regions of the morphants injected with MO1 or MO2,
indicating the cardiac-specific effects of zlrrc10 MOs. In
addition, neither scrambled control morpholino (CMO) nor
CMO-5m caused any significant morphological defects, which
indicates the specific effects of zlrrc10 MOs on Lrrc10
knockdown. Therefore, these results demonstrate that Lrrc10
is a critical factor for early cardiac development and suggest
cardiac functional defects in the zlrrc10 morphants.
Histology of the heart is abnormal in the zlrrc10 morphant
The zebrafish embryos were sectioned and stained with H&E
to analyze histology of the heart at 3 (results not shown) and
4 dpf (Fig. 3). By 48 hpf, the beginning of valve formation is
evident as endocardial cells at the AV junction become distinct
in morphology and gene expression, as they begin to form valve
cushions. Blood flow is a critical factor in valve formation, andPericardial edema (%)
MO1 n CMO n CMO-5m n MO2 n
5 51.7±6.2 125 2.5±1.0 145 3.6±1.0 82 38.6±0.6 45
3 80.6±4.9 124 2.6±1.0 114 7.5±1.3 66 66.3±3.8 43
2 88.4±7.1 107 1.9±1.2 91 7.7±1.5 50 23.6±3.6 32
1 99.4±0.6 80 3.2±1.9 77 9.3±0.2 43 17.1±2.9 31
O2, respectively. Data are shown as mean±SEM. n, the number of embryos.
Fig. 4. Reduction of zLrrc10 expression causes the defects in heart function. (A) Zebrafish embryos were injected with MO1 or CMO as indicated. To determine EDV
and ESV, time-lapse recording was used to follow ventricular movement from a lateral view in embryos at 3–5 dpf. (B) Stroke volume was calculated by subtracting
ESV from EDV. (C) Ejection fraction (%)=(EDV−ESV) /EDV×100. (D) Heart rate was calculated from the number of frames captured during three consecutive,
complete ventricular contractions in the time-lapse recordings. (E) Cardiac output was calculated as the product of stroke volume and heart rate. Values are
mean±standard error of the mean with n=10. An asterisk indicates a significant difference in values between the morphants and control at pb0.05. (F)
Representative fluorescence intensity images of the embryonic hearts are shown in vivo in lateral views with the head to the right using multiphoton microscopy. All
images of the control and morphant embryos were obtained at 3 dpf under identical experimental conditions at 780 nm excitation. (G) Relative amounts of NADHwere
calculated when the control value was set at 100%. n=4.
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man et al., 2004; Hove et al., 2003). After 48 hpf, the zebrafish
heart consists of a smooth-walled tube partitioned into all four
segments with the definite structure of sinus venosus, atrium,
ventricle, and bulbus arteriosus (Grimes et al., 2006; Hu et al.,
2000). Each part is externally identified by a constriction
between the segments. The myocardium is about one cell
thickness in the atrium, but the ventricle has two to three cell
layers. The heart is lined with endocardium, separated from the
myocardium by a layer of cardiac jelly in the atrium. The
ventricle and sinus venosus do not have a cardiac jelly layer.
There are no valves separating the segments at this stage.
At 4 dpf, the zlrrc10 MO1 morphants showed similar
abnormalities to the 3 dpf morphants. The position and
morphology of the bulbus arteriosus in the morphants seemed
normal (compare Figs. 3A and E). Two to three layers of
cardiomyocytes were observed in the ventricles of both the
morphants (Figs. 3F and G) and control (Figs. 3B and C).
However, prominent morphological defects were observed in
the ventricle of the zlrrc10 morphant, which was small and
compact compared to the control. The AV valve that is forming
seemed normal at the AV canal that was normally constricted
(compare Figs. 3C and G). The looping defect in the zlrrc10
morphant was clearly evident as shown in Fig. 3G, where the
atrium was located laterally as opposed to dorsally in the
control. This particular embryo has undergone a partial loopingprocess since the atrium was observed with the ventricle at the
same plane of section. A cross-section of the stretched, string-
like atrium was striking in the zlrrc10 morphant as compared to
the control (compare Figs. 3D and H). In both control and the
morphant, the atrial wall consisted of one myocardial layer and
the endocardial layer with space for cardiac jelly in between.
The impressive pericardial edema (indicated by an arrowhead)
was evident in all transverse sections of the morphant heart.
These results clearly demonstrate cardiac looping defects and
suggest possible defective cardiac chamber growth when Lrrc10
expression is reduced.
Knockdown of zLrrc10 resulted in cardiac functional defects
In addition to defective cardiac morphogenesis, the heart of
zlrrc10 morphants exhibited abnormal contraction. Vigorous
peristaltic contraction waves traversing the heart tube were
usually observed in wild type embryos by 36 hpf. In contrast,
the heart of the morphant seemed to beat weakly. Since normal
morphological development is critical for normal cardiac
function, we investigated the cardiac function as described in
Materials and methods. End-diastolic volume (EDV) and end-
systolic volume (ESV) were measured for the beating heart
(Fig. 4A). EDV was decreased in the zlrrc10 morphants during
the period of 3–5 dpf as compared to the control heart. The
decrease in EDV was prominent in the morphants at 5 dpf. In
Fig. 5. Knockdown of zLrrc10 causes a decrease in the number of cardiac
myocytes in developing zebrafish embryos. Transgenic zebrafish embryos
expressing RFP in the cardiomyocyte nuclei (cmlc2::dsRed2-nuc) were injected
with CMO or MO1. At the indicated time points, fluorescence images were
captured, and cells were counted in at least ten hearts per group. Embryos were
grown in the presence of 0.003% phenylthiourea from 1 dpf to inhibit
pigmentation, which is effective until 4 dpf. (A, B) Representative epifluores-
cence images of the CMO and MO1 injected cmlc2::dsRed2-nuc transgenic
zebrafish hearts at 3 dpf. (C) The number of cardiomyocytes per heart in CMO
and MO1 injected embryos. Values represent means±SEM. ∗pb0.01.
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of control. Accordingly, stroke volume and ejection fraction
were significantly reduced in the morphants, especially at 5 dpf
as compared to control during the course of study (Figs. 4B and
C). Heart rate was also significantly decreased in the morphants
compared to control (Fig. 4D). As a consequence of the reduced
stroke volume and heart rate, cardiac output was markedly
reduced (Fig. 4E), which led to embryonic lethality due to
cardiac failure (no contraction) by 6–7 dpf.
Metabolic regulation is inextricably linked with cardiac
function. This metabolism–function relationship is relevant to
diseases that lead to cardiac hypertrophy and heart failure (Huss
and Kelly, 2005). NADH is essential to generate ATP (Brandes
and Bers, 1996) and the amount of ATP has been shown to be
decreased in failing hearts because of decreased energy reserve
(Nascimben et al., 2004). To determine whether the knockdown
of zlrrc10 caused any perturbations in energy metabolism,
fluorescence intensity images of the heart at 780 nm were
collected in live zebrafish embryos using multiphoton micro-
scopy, which reflects the amount of NADH (Fig. 4F). We have
shown previously that the signal at 780 nm multiphoton
excitation is dominated by the NADH signal (Skala et al.,
2007). Interestingly, the fluorescence intensity in the morphant
heart was reduced by 45% as compared to control (NIH Image J
analysis), suggesting that energy reserve is likely reduced in the
morphant heart (Fig. 4G).
These results so far demonstrate that reduced expression of
Lrrc10 caused the decreased cardiac output during early
development, in part due to malformation of the heart. These
changes in the functional cardiac profile do not seem to
correlate to adult cardiac hypertrophy in human or mice where
there are no changes in ejection fraction. It should be noted that
there was a marked increase in EDV in normal embryos from 4
to 5 dpf, which reflects the normal functional changes during
development. The reduced EDV in the zlrrc10 morphant may
be attributed to an inability to dilate after the contraction or to
the defective cardiac chamber growth resulting in a small
ventricle. Therefore, we investigated whether the number of
cardiomyocytes is reduced in the morphant heart.
Myocardial cell number is reduced in the zlrrc10 morphants
Since the ventricle of the zlrrc10 morphants seemed smaller
than control, the atrium showed a string-like shape at 3–4 dpf
(Figs. 2 and 3), and EDV was reduced especially at 5 dpf (Fig.
4), we investigated whether chamber growth was defective in
these morphants. We used a transgenic zebrafish line (cmlc2::
dsRed2-nuc) where cardiomyocytes are marked by the nuclear
RFP to determine the effect of reduced Lrrc10 expression on the
number of cardiomyocytes in the heart. MO1 or CMO was
injected into cmlc2::dsRed2-nuc eggs after fertilization to count
cardiomyocytes (Figs. 5A and B). In the normal developing
heart, the number of cardiomyocytes per heart was significantly
increased from 3 to 4 dpf, indicating normal developmental
growth. In contrast, the total number of cardiomyocytes in the
zlrrc10 morphant heart was not significantly increased. Instead,
a 14.5% or 25.4% decrease in the total cardiomyocyte numberwas observed in the morphants at 3 or 4 dpf, respectively. These
results suggest that cell proliferation is defective in the heart of
the zlrrc10 morphant. However, it is not clear whether the
reduced cell number results from very early defects in cells in
the precardiac region (for example, reduced number of cardiac
precursor cells) or from proliferation defects during cardiac
development between 2 and 4 dpf. Although we have not
observed a marked increase in apoptotic cells in the morphant
heart (data not shown), we cannot exclude the possibility that
slightly increased or aberrant apoptosis may have caused the
reduced cardiomyocyte number or morphological defects in the
morphant.
Cardiac gene expression is deregulated in the zlrrc10
morphants
The results so far demonstrate profound morphological and
functional cardiac defects in Lrrc10 knockdown embryos. Next,
to determine the underlying causes of these cardiac defects, we
investigated alterations in gene expression of several important
cardiac marker genes in the heart of morphants (Fig. 6). Atrial
natriuretic factor (anf) gene expression in the zlrrc10morphants
was assessed because of its established responsiveness to
various physiological and pathological stimuli including those
causing hypertrophic or dilated cardiomyopathy in mammals
(Rockman et al., 1994b). As in other species, the zebrafish anf
gene is expressed in both the ventricle and atrium before
becoming restricted to the atrium (Berdougo et al., 2003). ANF
is known as a hallmark for cardiac hypertrophy because ANF
expression is switched off in the normal adult heart, whereas it
is re-expressed in hypertrophic and failing hearts. Whole-mount
in situ hybridization of anf showed a marked increase in anf
expression in both the ventricle and atrium of 2 day old
morphants (Fig. 6A, b and d) as compared to control (Fig. 6A, a
and c). These results suggest dysfunction of the heart in the
zlrrc10 morphants as early as 2 dpf, when the heart has just
Fig. 6. The expression levels of anf and cmlc2 were altered in the zlrrc10 morphants. (A) CMO (a, c, e, g, i and k) and MO1 (b, d, f, h, j and l) injected zebrafish
embryos at 2 dpf were subjected to whole-mount in situ hybridization using digoxigenin labeled anf (a–d) and cmlc2 (e–h) antisense riboprobes. Images of whole-
mount immunostaining usingMF20 antibody are shown in k and l. i and j are the same fields as k and l, respectively. c, d, g and h are ventral views and others are lateral
views, all with anterior to the left. Note the marked increase in anf expression in the zlrrc10morphant (b and d) but the reduction of cmlc2 expression in the morphant
(f and h). A ventral view of the morphant clearly shows the small ventricle and a looping defect (h). (B) For quantitative analyses of gene expression, RT-PCR was
performed on anf and cmlc2. β-actin was used as a control.
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morphology of this particular zlrrc10morphant seems normal at
this stage of development. Therefore, these results suggest that
induction of anf expression is very sensitive to altered cardiac
function.
We also examined expression of the gene encoding
sarcomere proteins such as cmlc2 and myosin heavy chain
(MHC) because genes encoding sarcomere components are
often altered in response to pathologic conditions (Antos et al.,
2002). cmlc2 has been shown to be expressed in embryonic
heart and to have a critical role in thick-myofilament assembly
and contractility in the zebrafish embryonic heart (Rottbauer et
al., 2006; Yelon et al., 1999). In the morphant at 2 dpf,
expression of cmlc2 was decreased in the ventricle and atrium
as compared to control (in Fig. 6, compare e and g to f and h),
which may be partly responsible for abnormal contractility and
reduced cardiac output. Since there was only a 14.5% reduction
in the cardiomyocyte number in the morphant at 3 dpf (see Fig.
5) and both the morphants and control have about two layers of
myocytes in the ventricular wall (see Fig. 3), it is unlikely that
the decreased expression of cmlc2 is entirely due to the reduced
number of cardiomyocytes. Looping defects and the small
ventricle were obvious in this morphant (Fig. 6A, f and h),
which are consistent with the results shown in Fig. 3. To obtain
quantitative expression data, semi-quantitative RT-PCR was
performed (Fig. 6B). Expression of anf was up-regulated about
73%, but cmlc2 was down-regulated about 50% as compared to
control (NIH Image J analysis), which correlates well with the
in situ hybridization results.
Immunostaining of zebrafish embryos with MF20 antibody
that recognizes sarcomere myosin heavy chain showed no
detectable changes in the expression level between the zlrrc10
morphants and control (compare Fig. 6A, k and l). These data so
far indicate that the zlrrc10 morphants exhibit increased
expression of anf, a hallmark for cardiac hypertrophy and
failure, but decreased expression of cmlc2.Discussion
Lrrc10 is essential for early cardiac development
To advance our understanding of early cardiac development,
we identified the cardiac-specific gene zlrrc10 and character-
ized its developmental roles in zebrafish in this study. We
demonstrated for the first time that zlrrc10 plays critical roles in
early cardiac development and cardiac function in the zebrafish
embryo. Decreased expression of Lrrc10 in the zebrafish
embryo resulted in a failure of the cardiac looping process and a
significant reduction in cardiac output. The cardiac insuffi-
ciency is likely a cause for embryos dying at 6–7 day post
fertilization when embryos require active transportation of
nutrients for survival and growth. The zebrafish has become an
attractive model for molecular biologists and geneticists, with
most studies focused on the early embryonic stages (Alexander
and Stainier, 1999; Chen et al., 1996; Weinstein and Fishman,
1996). Recently, information related to the morphology and
function of the developing as well as mature zebrafish heart
has been reported (Grimes et al., 2006; Hu et al., 2000; Hu et
al., 2001), which provides a framework for structure–function
analyses of the zebrafish cardiovascular system. The most
striking phenotype observed in the zlrrc10 morphants is a
cardiac looping failure accompanied by a large pericardial
edema at 2 dpf, suggesting cardiac insufficiency at a very early
developmental stage. The pericardial edema gets progressively
larger, which indicates that cardiac insufficiency worsens as
the zlrrc10 morphants develop.
It is often not clear whether morphogenic defects, a failure in
the looping process in this case, cause cardiac malfunctions or
vice versa since both looping defects and pericardiac edema
were simultaneously observed at the very early developmental
stage. It has been reported that proper cardiac contractility is
necessary for normal cardiac morphogenesis. Hemodynamic
parameters are known to be a determinant of myocardial growth,
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2003; Huang et al., 2003; Rottbauer et al., 2006) and adult heart
and may be important in the etiology of heart failure (Hutchins
et al., 1978; Rockman et al., 1994a). It has been postulated that
normal flow and hemodynamics are also crucial determinants of
normal cardiac morphogenesis and may play a causative role in
congenital heart disease (Sedmera et al., 1998). In this regard, it
is interesting that MO2, which is a much less efficient
morpholino than MO1 in inhibiting translation of zlrrc10,
caused looping defects that persisted during development.
However, the pericardial edema began to be improved at 4–
5 dpf, suggesting recovery of cardiac function. These results
indicate that cardiac malfunctions in zlrrc10 morphants were
not entirely due to morphogenic defects, but suggest an
independent role of Lrrc10 in morphogenesis from cardiac
function.
Underlying mechanisms of cardiac defects
Although we clearly demonstrated in this study that Lrrc10 is
essential for early cardiac development and function, the
molecular function of Lrrc10 remains to be elucidated. Due to
lack of a functional domain in Lrrc10, it is difficult to
hypothesize its exact molecular function from its deduced
amino acid sequence. The leucine-rich repeat (LRR) motif is
believed to function as a protein interaction domain. The
zLrrc10 protein contains seven LRRs without any other
functional domains as in mouse and human LRRC10. There-
fore, it is plausible that LRRC10 regulates cellular processes by
interacting with other factors that are critical for cardiac
development and function. LRRC10 has been reported to be
localized in the nucleus of immature cardiomyocytes, but in the
cytoplasm of adult cardiomyocytes in mice (Adameyko et al.,
2005). However, nuclear localization of LRRC10 in heart
sections has been reported in adult mice (Nakane et al., 2004).
This controversial but dynamic subcellular localization of
LRRC10 suggests that it has critical and possibly changing roles
as the heart matures. Therefore, it is necessary to further
investigate the molecular function of LRRC10 as a nuclear or
cytoplasmic factor. In this regard, the present study provides a
solid foundation to further study the molecular function of
LRRC10.
In an effort to determine what cellular changes occurred in
the zlrrc10 morphants, we have performed candidate gene
approaches (Fig. 6), which yielded two genes that are
deregulated in the zlrrc10 morphants. anf expression was
markedly increased both in the ventricle and atrium of the
zlrrc10morphant heart as compared to the control heart at 2 dpf.
The ANF gene is expressed very early in embryonic develop-
ment, at the stage when cells are committed to the cardiac
phenotype. Throughout embryonic and fetal development, ANF
expression characterizes both atrial and ventricular cells.
However, ANF is switched off in the normal adult heart, but
is re-expressed in hypertrophic and failing hearts. Therefore,
ANF is a biomarker for cardiac hypertrophy. Likewise, the
zebrafish anf gene is expressed in both the ventricle and atrium
before becoming restricted to the atrium (Berdougo et al.,2003). Although cardiac hypertrophic responses have not been
studied in the zebrafish embryonic heart, it is plausible that the
zlrrc10 morphants are undergoing similar responses to cardiac
hypertrophy/failure or cardiomyopathy as in the adult heart.
Indeed, anf induction was reported in zebrafish wea mutant
embryos, in which a loss of atrial function due to a mutation in
atrial myosin heavy chain (aMHC) resulted in the small and
compact ventricle (Berdougo et al., 2003).
Our candidate gene analyses indicate that cmlc2 in the heart
is decreased in the zlrrc10 morphants as compared to the
control heart. cmlc2 in zebrafish is expressed throughout the
heart, unlike the chamber-specific pattern reported for
regulatory MLCs in mouse and human. cmlc2 appears to be
the only regulatory mlc gene expressed in the heart of the
zebrafish (Rottbauer et al., 2006). It is well known that
mutations in the cardiac regulatory myosin light chain-2
(cmlc2) gene cause hypertrophic cardiomyopathy. Recently, a
mutation in zebrafish, tell tale heart (tel), which selectively
perturbs contractility of the embryonic heart and gives rise to a
defective morphology resembling looping defects, was identi-
fied as a mutation in the zebrafish cmlc2 gene (Rottbauer et
al., 2006). Ultrastructural analysis of tel cardiomyocytes
reveals complete absence of organized myofilaments, demon-
strating in vivo that Cmlc2 is required for thick filament
stabilization and contractility in the vertebrate heart. Therefore,
it is possible that the reduced cmlc2 expression in the zlrrc10
morphants is in part responsible for reduced cardiac output
leading to cardiac insufficiency.
It is interesting that the zlrrc10 morphants contain a reduced
number of cardiomyocytes at 3 and 4 dpf as compared to the
control heart. In the normal heart, the number of cardiomyo-
cytes significantly increases from 3 to 4 dpf whereas it does not
occur in the morphants. This reduced cardiomyocyte number in
the zlrrc10 morphants may in part lead to the decreased EDV
(Figs. 4 and 5), which in turn leads to cardiac insufficiency. It
remains to be elucidated whether the decreased cardiomyocyte
number in the morphants is primary or secondary to other
cellular defects. Our current data cannot distinguish whether
there are cardiomyocyte proliferation defects 3–4 dpf in the
zlrrc10 morphant heart or this decrease in cardiomyocyte
number is a result of a reduction in the number of cardiac
precursor cells in early embryos. Although we have not detected
any significant increases in apoptosis in the morphants (data not
shown, 2007), there is a possibility that aberrant apoptosis may
have caused the reduction in cell number. Apoptosis is a normal
process of developing organs, which is also required for normal
outflow tract development in chicken (Schaefer et al., 2004).
The developing heart does not show a high number of apoptotic
cells in the myocardium (data not shown, 2007), but apoptotic
cells are detected in certain regions such as the apex of the heart,
endocardial cushion area, and outflow tract during chicken or
mouse development (Schaefer et al., 2004; Wikenheiser et al.,
2006).
It is intriguing that total NADH amount in the morphant
heart was decreased in live zebrafish embryos (Fig. 4F). There
is a possibility that Lrrc10 directly regulates the metabolic
pathways that produce NADH. It has been demonstrated that
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and Kelly, 2005). Alternatively, energy metabolism may have
been altered as a consequence of cardiac malfunction/failure
caused by Lrrc10 knockdown. NADH provides the electron
transport chain with electrons necessary to build the proton
motive force, ultimately regenerating ATP from ADP and Pi
(Brandes and Bers, 1996). The amount of ATP has been
reported to be decreased in failing hearts because of decreased
energy reserve (Nascimben et al., 2004). In fact, heart failure of
any cause is associated with a decline in the activity of the
mitochondrial pathway (Huss and Kelly, 2005). We have
recently demonstrated that LRRC10 in the cytoplasm is not
localized in the mitochondria or at the sarcomeric Z-line, but is
localized at a diad region where the sarcoplasmic reticulum is
associated with the transverse tubule (Kim et al., in press).
Therefore, zLrrc10 may not directly regulate the mitochondrial
structure/function to regulate ATP production or be involved in
sarcomeric organization. It is likely that Lrrc10 knockdown
directly or indirectly caused reduced NADH amount and,
therefore energy reserve in the form of ATP. The fluorescence
intensity is mostly from NADH, but may include FAD (Bird et
al., 2004; Bird et al., 2005), which is also a source of ATP
generation. Although FAD can be detected with NADH in our
measurement, the NADH amount produced by the glucose
metabolism is five times higher than FAD that is mainly
produced by fatty acid metabolism (Berg et al., 2002).
Moreover, glucose is a preferred energy source in the embryonic
heart (Huss and Kelly, 2005; Scheuer, 2004). In addition,
spectral characterization of NADH and FAD at 780 nm using a
spectrofluorometer (Fluorolog, Horiba) indicates that the
primary signal is NADH (personal communication with Long
Yan).
Altogether we have discovered that Lrrc10 is essential for
normal cardiac development and cardiac function in the
zebrafish embryo. Because early cardiac morphogenic defects
accompanied by a pericardial edema were identified in the
zlrrc10 morphants, we now know that a previously unchar-
acterized factor in zebrafish plays critical roles in heart
development and function and could potentially be involved
in human congenital heart defects and/or certain types of adult
heart disease. Therefore, this study will provide the critical
insights into the complex mechanisms of normal cardiac
development, which will lead us to determine the molecular
basis of congenital heart defects, and adult cardiac disease.
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